BioPharma
biopharma nl
biotech IPO
Healthy Child
Healthy Man
Healthy Pets
Healthy Women
inflammatory bowel disease
News
Pharma
Precision Medicine
Prometheus Biosciences
San Diego
SYN
Top Story
Prometheus Bio’s IPO raises $190M for inflammatory bowel disease R&D
Prometheus Biosciences contends that the current treatments for inflammatory bowel disease are inadequate, taking a “one-size-fits-all approach” that doesn’t…